# First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

> **NCT03559166** · PHASE1 · COMPLETED · sponsor: **Blade Therapeutics** · enrollment: 88 (actual)

## Conditions studied

- Fibrosis

## Interventions

- **DRUG:** BLD-2660

## Key facts

- **NCT ID:** NCT03559166
- **Lead sponsor:** Blade Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-11
- **Primary completion:** 2019-10-04
- **Final completion:** 2019-10-04
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559166, "First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03559166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*